The melanocortin 1 receptor (MC1R) is a G-protein-coupled receptor (GPCR) crucial for the regulation of melanocyte proliferation and differentiation. MC1R activation by melanocortin hormones triggers the cAMP pathway and stimulates the extracellular-signalregulated protein kinases ERK1 and ERK2 to promote synthesis of photoprotective eumelanin pigments, among other effects. Signaling from most GPCRs is regulated by the b-arrestin (ARRB) family of cytosolic multifunctional adaptor proteins, which mediate signal termination and endocytosis of GPCR-agonist complexes. The ubiquitously expressed non-visual b-arrestin1 (ARRB1) and b-arrestin2 (ARRB2) are highly similar but not functionally equivalent. Their role in the regulation of MC1R is unknown. Using a combination of co-immunoprecipitation, gel filtration chromatography, confocal microscopy, siRNA-mediated knockdown and functional assays, we demonstrated agonist-independent competitive interactions of ARRB1 and ARRB2 with MC1R, which might also be independent of phosphorylation of Ser/Thr residues in the C-terminus of the MC1R. The effects of ARRBs were isoform specific; ARRB2 inhibited MC1R agonist-dependent cAMP production but not ERK activation, stimulated internalization and showed prolonged co-localization with the receptor in endocytic vesicles. By contrast, ARRB1 had no effect on internalization or functional coupling, but competed with ARRB2 for binding MC1R, which might increase signaling by displacement of inhibitory ARRB2. These data suggest a new mechanism of MC1R functional regulation based on the relative expression of ARRB isoforms, with possible activatory ARRB1-dependent effects arising from partial relief of inhibitory ARRB2-MC1R interactions. Thus, competitive displacement of inhibitory ARRBs by functionally neutral ARRB isoforms might exert a paradigm-shifting signal-promoting effect to fine-tune signaling downstream of certain GPCRs.
Introduction
The melanocortin 1 receptor (MC1R) regulates key aspects of melanocyte biology in response to its ligands, the peptide hormones a melanocyte stimulating hormone (aMSH) and adrenocorticotropin (ACTH) (García-Borrón et al., 2005; Slominski et al., 2004; Yamaguchi et al., 2007) . MC1R is a Gprotein-coupled receptor (GPCR) whose activation triggers the cAMP pathway leading to cAMP-dependent transcriptional activation of microphthalmia transcription factor (Levy et al., 2006) . In human melanocytic cells, MC1R also activates the extracellular signal regulated kinases (ERK) 1 and 2 independently of cAMP Herraiz et al., 2011a) . Active ERKs phosphorylate Microphthalmia to increase its activity (Hemesath et al., 1998) , thereby stimulating transcription of genes encoding for melanogenic proteins. Modulation of MC1R activity is responsible for much of the normal variation in mammalian pigmentation. High MC1R activity is associated with eumelanogenesis and darker pigmentation (Ito and Wakamatsu, 2011; Rees, 2004; Robbins et al., 1993) , whereas decreased or absent signaling leads to reddish pheomelanogenic pigment production (Beaumont et al., 2007; Duffy et al., 2004; Healy et al., 2000; Healy et al., 2001; Jiménez-Cervantes et al., 2001; Sánchez-Laorden et al., 2006; Walker and Gunn, 2010) . Following exposure to ultraviolet radiation (UVR), MC1R also activates DNA repair and survival mechanisms (Böhm et al., 2005; Kadekaro et al., 2005; Kadekaro et al., 2010) as well as antioxidant defences (Kadekaro et al., 2012; Maresca et al., 2010) . In human melanocytes, the low density of MC1R receptors on the plasma membrane is a limiting factor for the cAMP response to agonists (Herraiz et al., 2011b; Más et al., 2003) . Thus, availability of MC1R sites is an important regulatory factor, whose phenotypic impact is highlighted by changes in constitutive or UVR-induced pigmentation in carriers of MC1R alleles with altered cell surface expression (Beaumont et al., 2007; Sánchez-Laorden et al., 2006) .
The level of GPCRs on the plasma membrane and their functional coupling to signal transduction pathways are regulated by a small family of cytosolic proteins known as b-arrestins (ARRBs) which function as endocytic adaptors and signal terminators. Current models involve rapid phosphorylation of agonist-occupied receptors by dedicated GPCR kinases (GRK) resulting in recruitment of ARRBs, which uncouple the receptor from G proteins and initiate endocytosis (DeWire et al., 2007; Luttrell and Lefkowitz, 2002; Moore et al., 2007; Wolfe and Trejo, 2007) . The arrestin family comprises four members encoded by different genes (Gurevich and Gurevich, 2006a) . Two visual arrestins (arrestin 1 and arrestin 4, also called visual arrestin and cone arrestin, respectively) are expressed primarily in visual sensory cells. The nonvisual arrestins 2 and 3, most often called b-arrestin1 and b-arrestin2 (ARRB1 and ARRB2), are expressed ubiquitously and display a broad specificity for GPCRs (DeFea, 2011; Luttrell and Gesty-Palmer, 2010) . Several ARRB splice variants have been described but their functional differences are uncertain (Gurevich and Gurevich, 2006a) . Receptor-bound ARRBs act as scaffolds, linking GPCRs with the internalization machinery of the coated pit (DeFea, 2011; Moore et al., 2007) . This leads to regulated receptor endocytosis, followed by dephosphorylation and recycling to the plasma membrane (resensitization) or targeting to lysosomes or proteasomes for destruction (downregulation). Moreover, ARRBmediated endocytosis also triggers or modulates new signaling events by orchestrating the formation of signaling complexes called signalosomes, whose precise composition might depend on the ARRB isoform present in the complex (DeWire et al., 2007; Shenoy and Lefkowitz, 2003) . Although much has been learned about the general mechanisms of GPCR desensitization and internalization, a number of important questions remain partially unanswered. For instance, the role of agonist binding and GPCR phosphorylation on recruitment of ARRBs is not fully understood and may depend upon the specific GPCR under study (Gimenez et al., 2012) . For promiscuous GPCRs triggering several signal transduction pathways, the possibility of biased effects of the ARRBs on downstream signaling partners is largely unexplored. In addition, given the high sequence identity of ARRB1 and ARRB2, it is possible that at least for certain GPCRs, binding of different ARRB isoforms could be competitive, thus giving rise to a new layer of complexity of functional regulation.
We have previously shown that human MC1R desensitization is mediated by GRK2-or GRK6-dependent phosphorylation of amino acid residues T308 and S316 located in the C-terminal extension, and that MC1R is endocytosed following agonist binding (Sánchez-Laorden et al., 2007; Sánchez-Más et al., 2005a) . However, the role of nonvisual ARRB isoforms in regulating MC1R signaling remains unknown. We report a study of the differential regulation of MC1R function by ARRBs. We found that ARRB2 isoforms bound MC1R even in the absence of agonist and promote MC1R desensitization and internalization. On the other hand ARRB1 also associated with MC1R, but surprisingly failed to trigger desensitization or internalization. Moreover, we found evidence suggesting that ARRB1 competed with ARRB2 for the receptor. Accordingly, by virtue of competitive displacement of the inhibitory ARRB2, ARRB1 seemed to exert a paradigm-shifting signal-promoting effect. These data provide new insight on the regulation of MC1R signaling as well as on functional differences between ARRB isoforms that may be of general interest for other GPCRs.
Results

ARRB expression in human melanocytic cells
We checked ARRB1 and ARRB2 expression in HBL human melanoma cells and HEK293 cells, widely used as a heterologous model system for the study of GPCRs. Western blot with an anti-ARRB1 antibody that crossreacts with ARRB2 or with a specific anti-ARRB2 monoclonal antibody showed that ARRB1 levels were comparable in both cell types, but expression of ARRB2 was higher in HEK293 cells (Fig. 1A) . On the other hand, each nonvisual ARRB exists as several splice forms that share the N and C termini but differ in the use of internal exons (Gurevich and Gurevich, 2006a) . These isoforms are not easily resolved by electrophoretic techniques. To analyze the ARRB isoform repertoire in melanocytic cells, we used sets of PCR primers common for all splice variants, encompassing the initiation and termination codons of ARRB1 and ARRB2 (supplementary material Table S1 ). cDNA from HBL cells was amplified and amplicons were cloned into pcDNA3 and sequenced. We found that HBL cells express at least ARRB1 isoform 002 (accession number NM_020251, designated as ARRB1), ARRB2 isoform 201 (accession number NM_004313, designated ARRB2-201), and ARRB2 isoform 001 (accession number ABG47460, ARRB2-001). ARRB2-001 shares the same N-terminal sequence of the other ARRB2 splice variants, but contains an additional prolinerich 12 amino acid insertion near the C terminus resulting from the use of an alternative in-frame junction of exons 13 and 14. We confirmed expression of ARRB1, ARRB2-201 and ARRB2-001 in normal human melanocytes (NHM) by quantitative RT-PCR, using isoform-specific primers (supplementary material Table S1 ) and cDNA from a culture of normal human melanocytes, a gift from Z. Abdel-Malek (Fig. 1B) .
We obtained HA-tagged ARRB constructs by amplification of the native ARRB coding sequence with PCR primers pairs consisting of specific forward primers containing added restriction sites and the same reverse primers employed for the amplification and cloning of the native isoforms (supplementary material Table  S1 ). The amplicons were cloned in frame in the pCS2-3HA vector (gift from F. Margottin, Institut Cochin, INSERM, Paris, France) so as to generate a 3xHA tag fused immediately N-terminal to the ARRB isoforms. The tagged constructs were co-expressed with FLAG epitope-labeled MC1R within HEK293 cells or HBL melanoma cells. Western blots of detergent-solubilized cell extracts showed that all ARRB isoforms were expressed at comparable levels (Fig. 1C) , suggesting a similar intracellular stability. ARRB1 migrated as a majority band of apparent molecular mass near 50 kDa (Fig. 1C) . Conversely, ARRB2 isoforms migrated as doublets, consistent with reports by others (Nobles et al., 2007; Orsini and Benovic, 1998) . Co-expression of ARRBs and MC1R did not modify the steady state levels of total receptor protein assessed by western blot (Fig. 1C) . This was confirmed with an ELISA-based procedure that also allowed comparing the levels of cell surface MC1R (Fig. 1D) . In this case, a slight trend towards reduction of plasma membrane MC1R was found in cells expressing the receptor and ARRB1-002 or ARRB2-201 compared with cells expressing MC1R alone. However, the changes did not reach statistical significance, and no differences were found for the ARRB2-001 isoform. Overall, it appeared possible to compare the effects of ARRB isoforms on MC1R function without complicating factors such as differences in expression levels. function (Fig. 2) . ARRB2 isoforms, but not ARRB1, inhibited MC1R-dependent cAMP production in HEK293 and HBL cells ( Fig. 2A) . Interestingly, the extent and kinetics of melanocortininduced ERK phosphorylation were not affected by overexpression of the ARRBs in HBL cells (Fig. 2B) , suggesting a biased effect of ARRB2 on MC1R signaling.
Co-transfection of ARRB2 isoforms and MC1R decreased the binding of [
125 I]-NDP-MSH to HEK293 cells, compared with expression of MC1R alone. ARRB2 also inhibited radioligand binding to endogenous MC1R in HBL cells (Fig. 2C) . The concentration of radioligand used in these experiments (10 210 M) was within the range of the Kd reported . FLAG-labeled proteins were detected with anti-FLAG M2-peroxidase conjugate (1:7000, 30 min for permeabilized cells or 1 h at 4˚C for nonpermeabilized cells) using 3,39,5,59-tetramethylbenzidine as peroxidase substrate. Reactions were allowed to proceed in the dark, stopped with 100 ml of 1 M H 2 SO 4 and absorbance at 450 nm was read. The assays were performed using permeabilized or nonpermeabilized cells to compare total (white bars) and cell surface (black bars) expression. The cytosolic enzyme ornithine decarboxylase (ODC) labeled with the FLAG epitope was used as a control for lack of significant staining of intracellular proteins in non-permeabilized cells.
for NDP-MSH binding to MC1R (Herraiz et al., 2011b) . Therefore, our data do not allow distinguishing effects of ARRB2 on affinity or receptor number. On the other hand, ARRB1 had no inhibitory effect. MC1R internalization was next assessed by an acid-wash method that discriminates external from internal (acid-wash resistant) agonist-receptor complexes (Herraiz et al., 2011b; Sánchez-Laorden et al., 2007) . In line with equilibrium binding data, ARRB2 isoforms increased MC1R internalization in the presence of agonist, whereas ARRB1 had no effect (Fig. 2D) . 27 M NDP-MSH. Cells were solubilized in buffer containing phosphatase inhibitors (75 ml/well, PMSF 100 ng/ml, 1% Igepal, 2 mM imidazole, 1 mM NaF, 1.15 mM sodium molibdate, 1 mM sodium ovanadate and 4 mM sodium tartrate in PBS). Comparable aliquots were subjected to electrophoresis, blotted and probed for phosphorylated ERK1 and ERK2 (upper) or total ERK2 (lower), as a loading control. The fold change in the intensity of the pERK signal, corrected for loading and normalized to the zero time point in each series, is shown below each lane (mean of two independent experiments). (C) Effect of ARRB isoforms on the availability of NDP-MSH-binding sites. HEK293 or HBL cells grown in 6-well plates were co-transfected with MC1R and empty vector or the indicated ARRB isoforms, as required. At 48 h after transfection, specific [ The association of ARRB2 and MC1R suggested by the previous experiments was further analyzed by coimmunoprecipitation. HBL cells expressing FLAG-tagged MC1R were transfected with the native ARRB2-001 construct (designated ARRB2 for convenience) and challenged with 10 27 M NDP-MSH for up to 90 min. Detergent-solubilized extracts were immunoprecipitated for MC1R and the pellets were blotted to detect ARRB2. ARRB2 was detected in the pellets at all the time points (Fig. 3A) . This was confirmed by confocal microscopy, upon co-expression of FLAG-labeled MC1R and a green fluorescent protein (GFP)-ARRB2 fusion in HEK293 cells. Confocal micrographs showed detectable co-localization with GFP-ARRB2 at all time-points and a rapid redistribution of MC1R from the plasma membrane to internal vesicles following agonist stimulation (Fig. 3B ). This pattern persisted during the experiment, indicating stable association of MC1R and GFP-ARRB2 in endocytic vesicles. Quantitative analysis of the images by estimation of the Pearson coefficient of correlation showed a trend towards increased co-localization, with a statistically significant difference 30 min after the addition of agonist (Fig. 3C) . Association of MC1R and GFP-ARRB2 was further demonstrated by co-immunoprecipitation of the proteins from extracts of agonist-stimulated cells co-expressing both proteins (Fig. 3D) . Thus, ARRB2 was found in association with MC1R both under basal conditions and in the presence of agonist. 
Competitive association of ARRB1 and ARRB2 isoforms with MC1R
Thus far we have shown that overexpressed ARRB2 isoforms specifically decreased MC1R signaling to the cAMP pathway, and stimulated its sequestration. We sought to confirm these findings under more physiological conditions by siRNAmediated gene silencing in HBL cells. To this end, cells were transfected with ARRB1 or ARRB2-directed siRNA (supplied by Ambion, catalogue number s1622 and s1627, respectively). ARRB isoform-specific, strong downregulation was observed 72 h after transfection with residual ARRB levels around 20% (Fig. 4A) . We determined agonist-stimulated cAMP production following ARRB knockdown or overexpression. Unexpectedly, we found that downregulation of ARRB1 inhibited cAMP production, comparable with overexpression of the inhibitory ARRB2 (Fig. 4B) . The lack of significant changes in cAMP levels in agonist-stimulated cells following knockdown of the inhibitory ARRB2 was also surprising. Comparable results were obtained with a different siRNA purchased from another supplier (from Santa Cruz Biotechnology, catalogue number sc-29471 for ARRB1 and sc-29208 for ARRB2, results not shown). No apparent changes in agonist-dependent ERK activation were detected by western blot in siRNA-treated cells, arguing against off-target effects (Fig. 4C) . In fact, visual inspection of these blots might suggest a trend towards slightly longer kinetics in siRNA-treated samples, but quantification of band intensities in three independent experiments did not yield statistically significant differences at any of the time-points tested, up to 10 min (Fig. 4D) . On the other hand, treatment of MC1R-expressing HEK293 cells with ARRB1-directed siRNA had no Regulation of MC1R signaling by b-arrestins 3729 effect on agonist-dependent receptor internalization, as assessed by confocal microscopy (Fig. 4E ) or radioligand binding analysis (Fig. 4F) . Conversely, ARRB2-specific siRNA strongly repressed receptor internalization. Therefore, siRNA-mediated knockdown of ARRB1 specifically inhibited MC1R coupling to the cAMP pathway, but had no effect on agonist-promoted receptor internalization. Conversely, downregulation of ARRB2 abolished receptor internalization without effect on functional coupling.
The surprising finding that ARRB1 knockdown inhibited MC1R functional coupling to the cAMP pathway suggested an association of ARRB1 and MC1R that may decrease the interaction of the receptor with the inhibitory ARRB2. This scenario would also be consistent with lack of significant effects of ARRB2 downregulation on cAMP production. Thus, we further analyzed ARRB-MC1R interactions. Extracts of cells expressing HA-tagged ARRB isoforms alone or together with FLAG-labeled MC1R were chromatographed on a Sephacryl S-400 HR gel filtration column (fractionation range 20-8000 kDa). Fractions were collected to monitor elution of ARRBs and MC1R (Fig. 5A ). In the absence of MC1R, ARRB isoforms were significantly retained and eluted in fractions corresponding to apparent molecular weight (Mr) below 100 kDa, consistent with their known size. Co-expression of MC1R shifted strongly this elution profile since the ARRBs co-eluted with the receptor near the void volume, consistent with the presence of both proteins in high M r complexes. This suggested that ARRB1 and ARRB2 interact constitutively with the MC1R, in the absence of agonists. We confirmed agonist-independent ARRB-MC1R association by co-immunoprecipitation. Extracts of cells co-expressing HAlabeled ARRB and FLAG-MC1R were immunoprecipitated with an anti-HA monoclonal and the pellets were probed for MC1R by western blot (Fig. 5B) . Efficient, comparable and specific coimmunoprecipitation of MC1R and ARRB1 or ARRB2 was detected. Since phosphorylation of GPCRs by the GRKs is much more efficient for agonist-bound receptors, this result suggested that ARRB-MC1R association could occur in the absence of MC1R phosphorylation. To test this possibility, we compared ARRB1 co-immunoprecipitation with WT MC1R or its T308A-S316A or T308D-S316D double mutants (Fig. 5C, left) . In these mutants, two GRK target residues controlling the functional status of MC1R are mutated to abolish or mimic phosphorylation, respectively (Sánchez-Laorden et al., 2007) . The amount of ARRB1 immunoprecipitated with MC1R was comparable for WT and the mutants, consistent with a phosphorylationindependent association. Comparable results were obtained for ARRB2 (Fig. 5C, right) .
We next examined whether association of the ARRBs with MC1R was competitive. HEK293 cells were transfected to express FLAG-labeled MC1R, HA-labeled ARRB2-201 or a GFP-ARRB1-002 fusion in suitable combinations. MC1R was immunoprecipitated with anti-FLAG, and the pellets were probed for ARRB2 with anti-HA, or for ARRB1 with anti-GFP (Fig. 6A) . As expected, ARRB1 or ARRB2 expressed individually co-precipitated efficiently with MC1R. However, co-expression of ARRB1 significantly decreased the amount of ARRB2 in the immune pellets. We confirmed this competitive pattern in cells transfected with FLAG-MC1R, HA-ARRB1 and WT ARRB2-201. In this case, ARRB1 was immunoprecipitated from cell extracts with anti-HA monoclonal, and the pellets were probed for MC1R with anti-FLAG. Expression of ARRB2 decreased noticeably the amount of MC1R that co-immunoprecipitated with ARRB1 (Fig. 6B) . Similar results were obtained with cells transfected with HA-ARRB2 and unlabeled ARRB1 (not shown).
Further support for competitive association of ARRBs and MC1R was obtained by gel filtration chromatography (Fig. 6C) . HAlabeled ARRB2-201 was co-transfected with FLAG-MC1R, with or without unlabeled ARRB1. Extracts were chromatographed as above, and fractions were collected to monitor elution of ARRB isoforms and MC1R. Consistent with previous data, in the absence of ARRB1 the majority ARRB2 peak co-eluted with MC1R near the column's void volume, indicating its presence in high M r complexes. Conversely, for cells co-expressing both ARRB isoforms the elution profile of ARRB2 indicated limited coelution with MC1R, with a significantly retained major elution peak compatible with free ARRB2 (Fig. 6C) . Overall, these experiments support the notion of competition between ARRB1 and ARRB2 for binding MC1R, in the absence of agonist and independently of receptor phosphorylation.
We sought to confirm competition of ARRB1 and ARRB2 for MC1R at physiological levels of expression and in the presence of agonist. HBL cells stably expressing FLAG-labeled MC1R were treated with ARRB1 or ARRB2-directed siRNA. Extracts from control or agonist-challenged cells were immunoprecipitated for MC1R, and the pellets were probed for ARRB2 (Fig. 6D) . In resting cells, we found a very faint co-immunoprecipitation band for ARRB2 only when ARRB1 was silenced. The intensity of the ARRB2 band increased upon stimulation with NDP-MSH and knockdown of ARRB1. This finding further suggests that engagement of ARRB1 and ARRB2 into an MC1R-containing complex is competitive, mutually exclusive and occurs at physiological levels of expression. HEK293 cells were transfected with FLAG-MC1R and differentially labeled ARRB isoforms (HA-labeled ARRB2-201, and the GFP-ARRB1-002 fusion protein), alone or in combination. MC1R was immunoprecipitated from identical aliquots of detergent-solubilised cell extracts with an anti-FLAG, and the immune pellets were subjected to electrophoresis and blotted for the ARRBs (with antibodies against HA for ARRB2, or GFP for ARRB1), or for MC1R as a control for comparable efficiency of immunoprecipitation. Blots were also performed using detergent-solubilized extracts as input controls, as indicated. (B) Reduced co-immunoprecipitation of MC1R and ARRB1 following overexpression of ARRB2. Cells were transfected to express FLAG-MC1R, HA-labeled ARRB1 and wild-type (WT) ARRB2-201. Extracts immunoprecipitated for ARRB1 with anti-HA antibody were western-blotted and probed for MC1R (with anti-FLAG antibody) or ARRB1 (with anti-HA antibody). (C) Changes in gel filtration chromatography elution profiles of ARRB2-201 upon co-expression of MC1R in the presence or absence of ARRB1. HA-labeled ARRB2-201 was co-transfected with FLAG-MC1R alone or in combination with unlabeled ARRB1, as indicated. Detergent-solubilized extracts were subjected to chromatography on the same Sephacryl S-400 HR column as in Fig. 5 . ARRB isoforms and MC1R in the eluted fractions shown were analyzed by western blotting. (D) Co-immunoprecipitation of ARRB2 and MC1R is increased by receptor stimulation and by downregulation of ARRB1 expression. HBL melanoma cells stably expressing FLAG-MC1R were transfected with ARRB isoform-specific siRNA or a scrambled control (Scrb). At 48 h after transfection, cells were challenged with 10 27 M NDP-MSH for 5 min. Comparable aliquots of detergent-solubilized extracts from control or agonist-stimulated cells were immunoprecipitated for MC1R with an anti-FLAG monoclonal antibody, and the immune pellets were probed for ARRB2 with a specific commercial antibody or for MC1R (with anti-FLAG antibody) as a control for comparable loading and immunoprecipitation. As additional controls for input and efficiency of knockdown, aliquots were subjected to electrophoresis and blotted for ARRB1, ARRB2 or MC1R. We next looked for functional evidence further supporting this model. We took advantage of the differential effect of ARRB1 and ARRB2 on MC1R coupling to the cAMP pathway. HEK293 cells were transfected to express MC1R with ARRB1 and/or ARRB2, then challenged with NDP-MSH and cAMP production was quantified (Fig. 6E) . As expected, ARRB1 had no effect on activation of cAMP synthesis, as opposed to a strong inhibition by ARRB2. Moreover, cAMP production was significantly higher in cells co-expressing both ARRBs, compared with cells expressing exogenous ARRB2 exclusively. Again, this is consistent with competition of non-inhibitory ARRB1 and inhibitory ARRB2 for binding MC1R.
Finally, we obtained clones of HBL melanoma cells enriched in FLAG-labeled ARRB1 or ARRB2 (HBL-ARRB1 and HBL-ARRB2 cells, respectively). Western blots probed with anti-FLAG or ARRB-specific monoclonals allowed for selection of clones moderately overexpressing comparable levels of FLAG-ARRB1 or FLAG-ARRB2 (Fig. 7A) . Two independent clones of each type were selected to compare MC1R function. We found significantly higher agonist-induced cAMP production in HBL-ARRB1 cells. Conversely, functional coupling to cAMP synthesis was strongly repressed in HBL-ARRB2 cells (Fig. 7B) . Then, the rate of internalization of MC1R-agonist complexes was estimated. We found a small but significant reduction of internalization in HBL-ARRB1 cells compared with controls. These findings are consistent with a basal situation in HBL-ARRB1 cells where the increased ARRB1/ARRB2 ratio would cause a competitive displacement of ARRB2, thus promoting functional coupling to cAMP while hindering internalization. In agreement with this scenario, internalization was enhanced upon repression of ARRB1 by siRNA treatment. Conversely, HBL-ARRB2 cells showed high internalization rates that were not affected by siRNA-mediated knockdown of ARRB1, but that decreased significantly upon downregulation of ARRB2 (Fig. 7C ). These data further support competition of ARRB1 and ARRB2 for association with MC1R at nearly physiological levels of expression.
Discussion MC1R signaling plays a central role as a determinant of human skin phototype. The protective tanning response of UV-irradiated skin is largely dependent on paracrine production of MC1R agonists (Cui et al., 2007) and induction of MC1R expression in melanocytes (Corre et al., 2006) . MC1R activation stimulates melanogenic enzymatic activities within melanocytes (Ito and Wakamatsu, 2011; Le Pape et al., 2008) and also triggers DNA repair mechanisms (Böhm et al., 2005; Kadekaro et al., 2005; Kadekaro et al., 2010) and antioxidant defenses (Kadekaro et al., 2012; Maresca et al., 2010) that act coordinately to limit the cytotoxicity and carcinogenic potential of UVR. Thus, carriers of hypomorphic MC1R variants normally display an inefficient or absent tanning response (Healy et al., 2000; Rees, 2004 ) and a higher risk of melanoma and non-melanoma skin cancer (Box et al., 1997; Box et al., 2001; Duffy et al., 2004; Duffy et al., 2010; Palmer et al., 2000) . In keeping with this important biological role, MC1R signaling is highly regulated not only by general mechanisms such as homologous desensitization acting on most if not all GPCRs (Sánchez- Más et al., 2005a) , but also by specific mechanisms restricted to the MCR subfamily of GPCRs (Barsh et al., 2000; Pérez-Oliva et al., 2009; Walker and Gunn, 2010) . Previous work from our laboratory showed that whereas MC1R signaling to the cAMP pathway is downregulated by GRK2-and GRK6-dependent homologous desensitization (Sánchez- Más et al., 2005a) , only GRK6 is involved in agonistpromoted receptor internalization (Sánchez-Laorden et al., 2007) . We have now analyzed the regulatory role of ARRB1 and ARRB2 on MC1R functional coupling and cell surface expression.
GPCRs have been classified into two types based on their affinity for ARRBs and their trafficking patterns (Oakley et al., 2000; reviewed in DeWire et al., 2007; Shenoy and Lefkowitz, 2003) . Class A receptors display higher affinity for ARRB2 than for ARRB1, form short-lived complexes with ARRBs and are rapidly trafficked to lysosomes for degradation or recycled to the cell surface. Class B receptors bind both ARRBs with comparable affinity and form stable complexes with prolonged co-localization in endocytic vesicles. Our results show that human MC1R is a Class B GPCR with comparable affinity for ARRB1 and ARRB2 under basal conditions, which displays a stable association with ARRB2 in endocytic vesicles following stimulation with agonist. We have not attempted to identify the binding sites for ARRB1 and ARRB2 within the MC1R. However, a clear competition between ARRB1 and ARRB2 was observed in co-immunoprecipitation, gel filtration and functional assays. Accordingly, the binding sites for both arrestins should be at least partially overlapping. As far as we know, direct evidence of competitive displacement of human ARRB1 and ARRB2 for binding to a same GPCR has not yet been reported, although it could be anticipated on the basis of the extensive sequence identity and very similar folding pattern of the ARRB isoforms (Gurevich and Gurevich, 2006b) . Moreover, it is fully consistent with the finding that the same 29-mer peptide derived from the C-terminal sequence of the V 2 vasopressin receptor is able to bind both rat ARRB1 and ARRB2 (Nobles et al., 2007 : Xiao et al., 2004 .
Interestingly, confocal microscopy, co-immunoprecipitation analysis and gel filtration chromatography showed that MC1R can engage the ARRB isoforms either in the presence or the absence of agonist. Previous work from several laboratories has shown that human MC1R displays high agonist-independent constitutive activity (Chluba-de Tapia et al., 1996; Healy et al., 2001; Sánchez-Más et al., 2004) . The ability of the receptor to adopt an active conformation in the absence of activatory ligands might account, at least partially, for these agonist-independent interactions. On the other hand, the similar ARRB binding to WT MC1R or to the phosphorylation-incompetent T308A-S316A mutant strongly suggested the occurrence of phosphorylationindependent ARRB engagement. Accordingly, phosphorylation of receptor C-terminal residues by GRKs did not appear strictly necessary for ARRB recruitment, as shown for a few other GPCRs (Azzi et al., 2003; Gesty-Palmer et al., 2006; Wang and DeFea, 2006; Zoudilova et al., 2007) , although it may play a role on the fate and/or stability of the complexes. However, it has been shown for other GPCRs that removal of primary GRK targets can switch phosphorylation to secondary targets (Seibold et al., 1998) that may contribute to the recruitment of ARRBs. Therefore, although it is clear that phosphorylation of the T308 and S316 residues in the cytosolic extension of MC1R is not required for ARRB binding, a potential role for the phosphorylation of other intracellular residues cannot be formally excluded.
Interestingly, ARRB binding to resting WT MC1R did not appear to trigger receptor internalization in the absence of agonists, since i) ARRB1 overexpression had no effect on the rate of receptor internalization and ii) expression of ARRB2 did not decrease significantly MC1R immunoreactivity on the surface of non-permeabilized cells in the absence of agonist (Fig. 1D) . Thus, our data suggest that ARRB engagement is not sufficient to trigger MC1R internalization, and that stable plasma membraneassociated MC1R-ARRB complexes can exist in resting melanocytic cells. Given the ability of ARRBs to scaffold components of several signaling pathways, these complexes may have still uncharacterized functional consequences.
On the other hand, our results clearly showed isoform-specific effects of ARRB binding to MC1R. ARRB1 did not inhibit functional coupling to downstream signaling pathways nor did it trigger MC1R internalization, either in the presence or absence of agonists. Conversely, ARRB2 decreased functional coupling to the cAMP pathway and ARRB2 stimulated endocytosis of agonist-receptor complexes, with prolonged sequestration in intracellular vesicles. Thus, our findings fully support the emerging notion that in spite of extensive structural homology, nonvisual ARRB isoforms are not functionally redundant, but can perform specific functions (DeFea, 2011; Gesty-Palmer et al., 2006; Gurevich and Gurevich, 2006a; Luttrell and Gesty-Palmer, 2010; Luttrell and Lefkowitz, 2002) . Notably, ARRB2 did not impair MC1R functional coupling to the ERK pathway. We have shown that activation of the ERKs by human MC1R relies on the cAMP-independent transactivation of the cKIT receptor tyrosine kinase (Herraiz et al., 2011a) . We have also shown that many natural or artificial MC1R mutations decrease MC1R coupling to the cAMP pathway without effects on ERK activation (Herraiz et al., 2012) . Thus, activation of the cAMP and ERK pathways downstream of MC1R most likely involves a different set of effectors and structural requirements. Accordingly, a differential effect of ARRB2 on these pathways appears possible.
The different effects of ARRB1 and ARRB2 on MC1R functional coupling together with the occurrence of comparable affinity and competitive binding suggest the possibility of two functional profiles for MC1R, depending on the relative levels of ARRB isoform expression. If the intracellular concentration of ARRB1 is higher than ARRB2, then ARRB1-MC1R complexes should be more abundant than ARRB2-MC1R complexes. This would favor MC1R signaling activity, with less efficient desensitization and an inhibited internalization. However, if ARRB2 activity is higher than ARRB1, then MC1R would be mainly bound to the desensitization-promoting ARRB2 isoform, and its signaling would be impaired. This possibility is supported by our finding of markedly different agonist-promoted stimulation of cAMP production or receptor internalization rates in clones of HBL moderately overexpressing each one of the ARRB isoforms. Moreover, given that ARRBs behave as scaffolds with slightly different partner specificities, the signaling complexes nucleated by the MC1R might also be different. Accordingly, it can be hypothesized that the same number of MC1R molecules would determine different functional outputs depending on the ratio of ARRB1 to ARRB2 activity, thus suggesting a new mechanism of MC1R functional regulation. It will be important to see if differences in ARRB1/ARRB2 ratio are found in human melanocytes of different phototype but identical MC1R genotype.
Previous work from Robert Lefkowitz's laboratory first demonstrated reciprocal functional effects of siRNA-mediated downregulation of the two ARRB isoforms. In a study of ERK activation downstream of the angiotensin II type 1A receptor (AT 1A R), it was shown that downregulation of ARRB1 increased AT 1A R-dependent ERK activity, whereas ARRB2 silencing had the opposite effect (Ahn et al., 2004) . This led to the concept of functional competition in an ARRB-dependent, G-proteinindependent signaling pathway. Here we have shown competition between ARRB1 and ARRB2 for binding MC1R, and we have provided strong evidence suggesting functional effects of such competition on G-protein-dependent signaling events. Overall, the combination of competitive ARRB binding to specific GPCRs on one hand, and nonredundancy of ARRB action on the other, suggests a paradigm shift whereby a noninhibitory ARRB might, under certain circumstances, protect rather than downregulate GPCR signaling by displacing a desensitization-promoting ARRB isoform. Analysis of differential MC1R regulation by the functionally silent ARRB1 as opposed to a strongly inhibitory ARRB2 provides an example of this type and suggests that coupling of MC1R to the cAMP pathway might be fine-tuned by the relative expression of the ARRB isoforms. , MA) , and mMACs Protein G microbeads from MiltenyiBiotec (Bergisch Gladbach, Germany). Reagents for SDS-PAGE and western blot were from Bio-Rad (Richmond, CA, USA). Other reagents were from Merck (Darmstadt, Germany) or Prolabo (Barcelona, Spain).
Materials and Methods
Materials
Cell culture and transfection HEK293 cells and HBL cells (LOCE-MM1, established in the LOCE, Université Libre de Bruxelles, Belgium, a gift from Prof. G. Ghanem) were grown in DMEM with 10% fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin sulfate. Clones of stably transfected HBL cells were obtained as described (Más et al., 2003) and grown in the presence of 2% G418 (Calbiochem). Cells were transfected with Lipofectamine 2000 according to manufacturer's instructions. For siRNA-mediated knockdown of ARRB expression, oligonucleotides from two different suppliers were used, with comparable results. Cells were grown in 12-well plates to ,80% confluence and transfected using Opti-MEM to dilute the siRNA, and Lipofectamine 2000. When siRNA from Santa Cruz Biotechnology was employed (sc-29741 for ARRB1, sc-29208 for ARRB2), cells were transfected with 0.3 mg of the expression construct and 0.5 mg of specific 19-25 nt siRNA (corresponding roughly to 10 mM). A scrambled negative control siRNA (sc-44230) was used. For transfection with siRNA from Ambion, 0.2 mg of ARRB1-specific (s1622), ARRB2-specific (s1627) 21 nt siRNA, corresponding to a final concentration of 60 nM/well, or negative control siRNA 1 were employed. Cells were incubated with the siRNA transfection mix 6 h at 37˚C in a CO 2 incubator. Normal growth medium was replaced, and cells were further grown for 72 h.
Expression constructs
MC1R constructs in pcDNA3.0 have been described (Sánchez-Laorden et al., 2007) . To obtain ARRB expression constructs, the coding sequences of ARRB1 and ARRB2 were PCR-amplified using cDNA from HBL cells as target, Pfu DNA polymerase and primers containing added restriction sites for cloning into pcDNA3.1. These plasmids were used as templates in subsequent PCR reactions to obtain the other constructs. N-terminal 3xHA-labeled ARRB isoforms were obtained by amplification with suitable primers and cloning into pCS2-3HA, courtesy of F. Margottin (Institut Cochin, INSERM, Paris, France). GFP fusion constructs were obtained using the pEGFP-C1 vector (Clontech). Constructs were verified by automated sequencing in both strands. Primer sequences are shown in supplementary material Table S1 .
Binding and internalization assays
Radioligand binding assays have been described (Pérez Oliva et al., 2009; Sánchez-Laorden et al., 2009; Sánchez-Más et al., 2005b) . Cells grown in 6-well plates were transfected as required. 48 h after transfection, cells were serumdeprived for 3 h and incubated for 1 h in 500 ml/well of DMEM containing [ 125 I]-NDP-MSH (10 210 M, 0.1 mCi). Cells were washed with ice-cold PBS, harvested and counted for radioactivity in a gamma counter. Nonspecific binding was estimated with excess unlabeled NDP-MSH (10 26 M), or cells transfected with empty vector, with similar results. To estimate internalization of agonist-receptor complexes, an acid wash procedure was used (Sánchez-Laorden et al., 2007) . Cells were incubated (90 min, 37˚C) with [ 125 I]-NDP-MSH isotopically diluted to a final concentration of 10 29 M and 10 5 cpm, washed with cold serum-free RPMI followed by two 2-3 min ice-cold acid washes with 0.5 ml of 50 mM glycine and 150 mM NaCl, pH 3.0. The acid washes were pooled and counted to determine the amount of non-internalized ligand bound on the cell surface. Cells were trypsinharvested and counted for internalized receptor. Internalization indexes were defined as the percentage of internal relative to total ligand bound.
cAMP assays
Cells grown in 12-well plates were transfected, serum-deprived (at least 3 h) and stimulated as required. The medium was aspirated and the cells quickly washed with 800 ml ice-cold PBS were lysed with 200 ml/well 0.1N HCl preheated at 70˚C, and scrapped. The mix was freeze-dried, washed twice with 100 ml H 2 O and freeze-dried again. cAMP was measured with a radioimmunoassay kit (Amersham) or an enzyme immunoassay (R&D Systems) with similar results. Parallel dishes were used for protein determination with bicinchoninic acid.
Laser scanning confocal microscopy Cells grown on coverslips were transfected, fixed with 4% paraformaldehyde in PBS and permeabilized with 0.5% Igepal. Cells were labeled with anti-FLAG monoclonal (1:7000), followed by an Alexa 568 secondary (emission gated in the 550-707 nm) for detection of MC1R. GFP fusion proteins were detected by their intrinsic fluorescence (emission gated at 500-550 nm). Samples were mounted with a medium from Dako (Glostrup, Denmark) and examined with a Leica laser scanning confocal microscope AOBS and software (Leica Microsystems GmbH, Wetzlar, Germany). 102461024 pixels images were taken in sequential scan mode between frames, with a HCX PL APO CS 636objective and a pinhole of 1, corresponding to 114.73 mm. For quantitative estimation of co-localization of MC1R and GFP-ARRB2, the Pearson coefficient of correlation for emission of Alexa 568 and GFP was determined for at least 10 different cells using the ImageJ software (freely available at http://rsb.info.nih.gov/ij).
Immunoprecipitation and western blotting
Cells grown on 6-well plates were washed with PBS and solubilised in 200 ml solubilization buffer (50 mM Tris-HCl pH 7.5, 1% Igepal, 1 mM EDTA, 0.1 mM PMSF, 10 mM iodoacetamide). Samples were centrifuged (105,000 g, 30 min) and a suitable volume of supernatant was mixed (2:1 ratio) with sample buffer (180 mM Tris-HCl, pH 6.8, 15% glycerol, 9% SDS, 0.075% Bromophenol Blue, 7.5% b-mercaptoethanol). For immunoprecipitation, 2610 6 cells were washed, solubilised and centrifuged as above. Supernatants were precleared with 40 ml of mMacs protein G microbeads slurry for 1 h. The mixture was loaded onto a mColumn and the flow-through lysate was incubated with the required antibody (1-2 mg) and 50 ml of microbeads (1 h at 4˚C). Samples were applied to the column, washed, and eluted with pre-heated (95˚C) electrophoresis buffer. Electrophoresis and western blotting were performed as described (Sánchez-Laorden et al., 2006) . Comparable loading was ascertained by stripping and reprobing the membranes with an anti-ERK2 antibody.
Column chromatography
Cells appropriately transfected and grown on 10 cm diameter plates were solubilised in 500 ml solubilization buffer. The detergent-solubilized cell extract was loaded onto a 3061 cm column packed with Sephacryl S-400 HR (Sigma Aldrich), equilibrated and eluted with 50 mM Tris-HCl pH 7.5, 0.2% Igepal, 1 mM EDTA. 0.5 ml fractions were collected starting immediately before the void volume of the column, determined with Dextran Blue. 20 ml of selected fractions were analysed by western blot.
Statistics
Results are given as mean6s.e.m. for experiments performed at least twice, with independent duplicates (n §4), unless specified otherwise. Statistical significance was assessed with an unpaired Student's t-test performed with the GraphPadPrism package (GraphPad Software, San Diego, CA).
